Connect with us

Media OutReach

Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award

Published

on

  • Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy
  • One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time
  • Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical achievements visible – and honor those who, with courage, vision, and humanity, are shaping the medicine of tomorrow.”

WIESBADEN, GERMANY – Newsaktuell – 18 November 2025 – At a festive ceremony in the Hessian State Chancellery, Dr. Carl June (University of Pennsylvania) and Dr. Michel Sadelain (Columbia University) were presented with the inaugural Broermann Medical Innovation Award by Minister President Boris Rhein.

With a €1 million endowment, the Broermann Award ranks among the world’s most prestigious medical honors. Founded by Dr. Bernard große Broermann, the visionary founder of the Asklepios Group, the award recognizes the pioneering achievements of the two scientists in developing CAR-T cell therapy for the treatment of cancer.

In the presence of numerous representatives from science, politics, and society, Minister President Rhein honored the work of the award winners and their contribution to the treatment of cancer patients worldwide:

“With their work, Dr. Carl June and Dr. Michel Sadelain demonstrate the immense power that knowledge and passion can unleash. They have the potential to positively impact countless lives.” The head of government presented the Broermann Prize, worth a total of one million euros — one of the world’s most highly endowed awards of its kind praising their “groundbreaking work,” saying: “Dr. Carl June and Dr. Michel Sadelain show that knowledge can change lives and give people new hope for healing.” He further emphasized “The two prizewinners are inspiring role models through their attitude and dedication. With their insight that the immune system itself can become a weapon against cancer, they have opened a new chapter in cancer therapy.”

Prof. Dr. Werner Seeger, Chair of the Broermann Award Jury, emphasized:

“Today’s award ceremony marks a milestone for medical science. Dr. Carl June and Dr. Michel Sadelain have fundamentally transformed cancer treatment through their work on CAR-T cell therapy. Their dedication and pioneering spirit embody the very essence of medical innovation that this award celebrates.”

Dr. Michel Sadelain, Director of the Columbia Initiative in Cell Engineering and Therapy (CICET), accepted the award on behalf of himself and his colleague Dr. Carl June, Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania.

“It is a great honor to receive this recognition together with my colleague Carl June,” said Dr. Sadelain. “We are delighted that our decades of work on CAR-T cell therapy are being recognized internationally. This award is both validation and inspiration to continue advancing our research and developing new treatment options for patients with life-threatening diseases. It is a tremendous motivation for our teams and a resolute dedication to bringing better therapies for patients worldwide.”

Titia Olivia große Broermann, shareholder of the Asklepios Kliniken Group, added:

“For me, this award is more than recognition of scientific excellence – it is a living legacy of my husband’s vision. Bernard große Broermann believed that health should not be left to fate but can be shaped through innovation and care. Today, scientists like Michel Sadelain and Carl June have made this conviction a reality. Their groundbreaking research has transformed medicine and given countless cancer patients new hope – and, in many cases, a new life. For that, we owe them deep gratitude and great respect.”

About the Research

Dr. Carl June and Dr. Michel Sadelain were honored for their pioneering role in the genetic engineering of T cells to specifically target and destroy cancer cells. Using chimeric antigen receptors (CARs), these modified immune cells can identify cancer cells and eliminate them. CAR-T cell therapies have achieved remarkable success in treating leukemia, lymphoma, and multiple myeloma, opening an entirely new chapter in cancer therapy.

About the Laureates

Dr. Carl June (born 1950, Denver, USA) received his M.D. from the Baylor College of Medicine, his Ph.D. from the Fred Hutchinson Cancer Research Center, and founded the Center for Cellular Immunotherapies (CCI) at the University of Pennsylvania in 1999. He currently holds the Richard W. Vague Professorship in Immunotherapy.

Dr. Michel Sadelain (born 1960, Paris, France) earned his M.D. from the University of Paris in 1984 and his Ph.D. from the University of Alberta in 1989. After postdoctoral research at the Whitehead Institute for Biomedical Research (MIT), he joined the Memorial Sloan Kettering Cancer Center in New York in 1994. He now leads the Columbia Initiative in Cell Engineering and Therapy (CICET), founded in 2024.

Pictures from the award ceremony will be available shortly after the event at the following website: https://www.broermann-award.org/press/

Broermann Medical Innovation Award

Contact: Corinna Larsen

Tel.: +49 (0) 641 / 985-42302

E-mail: [email protected]

Visit Broermann Medical Innovation Award online and on social media:

www.broermann-award.com

www.facebook.com/people/Broermann-Medical-Innovation-Award/61567211302915/

www.linkedin.com/company/broermann-medical-innovation-award/

www.mastodon.social/@BroermannMedicalnnovationAward

www.instagram.com/broermannaward

Asklepios Kliniken

Coroporate Communications Marketing Department

Tel.: +49 (0) 40 / 18 18-82 66 36

E-mail: [email protected]

24—hour press-office on-call service: +49 (0) 40 / 1818-82 8888

Visit Asklepios online and on social media:

www.asklepios.com

www.asklepios.com/gesundheitsmagazin

http://www.youtube.com/asklepioskliniken

de.linkedin.com/company/asklepios

www.instagram.com/asklepioskliniken/

www.facebook.com/asklepioskliniken

The issuer is solely responsible for the content of this announcement.

About the Broermann Medical Innovation Award

The Broermann Medical Innovation Award was established in 2024 by Dr. Bernard große Broermann, founder of the Asklepios Kliniken. Guided by his vision to create a healthcare organization that delivers real benefit to patients through innovation, Asklepios became a pioneer in medical technology and digital healthcare solutions. The award continues his legacy, honoring those whose groundbreaking work improves lives and shapes the future of medicine.

Call for Nominations – 2026 Award

The nomination phase for the Broermann Medical Innovation Award 2026 is now open. Nominations of scientists who have made pioneering contributions to medicine, biotechnology, or related disciplines are welcome until March 1, 2026. Further details on eligibility and selection criteria are available on the award’s official website.

Media OutReach

Siam Piwat redefines global retail with NEXTOPIA, a future prototype where sustainability is a transformative force for business, people, and the planet

Published

on

BANGKOK, THAILAND – Media OutReach Newswire – 12 May 2026 – In a bold bid to reshape the future of retail, Siam Piwat Group has unveiled NEXTOPIA at its flagship Siam Paragon, the world’s first prototype for a global sustainability platform that turns eco-conscious living into an immersive, everyday experience.

Chief Executive Officer Chadatip Chutrakul introduced the project during The Economist’s 5th annual Sustainability Week Asia, recently held in Bangkok, positioning NEXTOPIA as more than a response to necessity but as a genuine driver of business leadership and vision.

The vision for the future of retail is built on three interconnected pillars: co-creation with founders and partners, collaboration with tenants and communities, and customers. Together, they redefine retail as a platform shaped by shared purpose, creativity, and participation. This extends to redefining customer relationships through trust, inspiring customers to visit more often, spend more time, and deepen engagement within our ecosystem.

2. NEXTOPIA (ECOTOPIA).jpg

“Sustainability is no longer optional,” Chutrakul said. “We must accelerate and make a bold move. Real, lasting impact is never created alone. It requires co-creation across industries, united by purpose, in a place that captures the world’s attention and inspires change for the greater good.”

Launched in November 2025, the 15,000-square-meter attraction at Siam Paragon, a global landmark that draws more than 200,000 visitors daily, including a significant share of international tourists aims to move sustainability “beyond awareness into joyful and engaging experiences in everyday life,” she added.

Developed with more than 50 partners, NEXTOPIA operates under the theme “Co-creating Communities for a Better World.” It features infrastructure contributions from companies including B.Grimm, SCG, Indorama and Kasikornbank, incorporating solar energy, sustainable materials, advanced water systems, and cooling and clean air technologies.

4. NEXTOPIA.jpg

The project has achieved zero waste to landfill, cut energy consumption by 47%, reduced water use by 34% and lowered carbon emissions from construction materials by 59%. Within a year, water savings are projected to be equivalent to the volume of an Olympic-sized swimming pool. Over two years, decarbonization efforts will deliver the environmental benefit of creating a vast urban park.

NEXTOPIA is Thailand’s first multi-tenant retail building to earn EDGE Advanced certification for resource efficiency and a two-star Fitwel rating. It also received the Best in Building Health Award 2026 from Fitwel, achieving top scores for its design and quality-of-life features.

Tenants must adhere to some 50 sustainability criteria covering waste management and value chain practices, with many exceeding standard industry benchmarks. Siam Piwat developed the framework over three years to help partners adopt sustainable practices quickly while cutting costs and unlocking new value.

Interactive elements at NEXTOPIA invite visitors to participate directly, with kinetic floors and bicycles that generate electricity for redeemable rewards, alongside exhibits featuring Thailand’s largest collection of recycled art, created by artists from waste collected nationwide. ECOTOPIA, the country’s biggest eco-store, stocks more than 110,000 sustainable products, many recycled or upcycled, sourced from around 300 Thai communities and small businesses.

The project has also brought together more than 30 local communities and global organizations, including the United Nations, World Food Programme, UNDP Biofin and WWF, to exchange knowledge and ideas.

More than a shopping destination, NEXTOPIA functions as a living laboratory for experimenting and exchanging ideas that retail and real estate developers worldwide could adapt. It marks a strategic evolution for Siam Piwat, transforming the company from a premier retail developer into what it describes as “a global sustainability platform” that links businesses, people and innovation.

This shift aligns with intensifying global pressure on companies to meet their sustainability commitments under the Paris Agreement, as brands and consumers increasingly demand verifiable environmental action.

With NEXTOPIA, Siam Piwat is betting that the future of retail lies not just in selling goods, but in creating spaces where sustainability feels tangible, measurable and above all inspiring.

Setting a new benchmark for co-created, revolutionary retail, NEXTOPIA offers a scalable model that delivers both business value and meaningful impact – one that can be adopted globally.

Hashtag: #SiamParagon #NEXTOPIA #Sustainability #PrototypeCity #NetZero #TheEconomist #SustainabilityWeekAsia

The issuer is solely responsible for the content of this announcement.

About Siam Piwat

Siam Piwat is a leading retail and real estate developer behind Bangkok’s most iconic destinations, including Siam Paragon, Siam Center, Siam Discovery, ICONSIAM, and Siam Premium Outlets Bangkok, globally recognized for pioneering experiential destinations.

For over six decades, Siam Piwat has been renowned for creating iconic destinations and world-class experiences, continuously redefining Bangkok’s retail landscape through award-winning developments that set new global benchmarks. Guided by creativity, innovation, and sustainability, the company continues to lead with a bold vision s that inspire, engage, and delight customers from around the world, while creating long-term value for society, businesses, and future generations.

Continue Reading

Media OutReach

DTAP Expands Access to Sexual Health Services with Two New Clinics in Holland Village and Clarke Quay

Published

on

SINGAPORE – Media OutReach Newswire – 13 May 2026 – DTAP, Singapore’s pioneering GP+ medical provider established in 2005, announced the opening of two new clinics – DTAP Clinic @ Holland Village, which officially opened on 29 Apr 2025, and DTAP Clinic @ Clarke Quay, which officially opened on 23 May 2025. The expansion strengthens access to general and sexual healthcare services, including STD tests, STD screening and HIV tests, within central lifestyle districts.

As healthcare-seeking behaviours continue to evolve, there has been a noticeable shift towards earlier and more proactive screening, especially for sexually transmitted infections (STIs) and HIV. Increasing public awareness of the importance of timely testing and treatment has driven demand for accessible, confidential care delivered in a professional clinical setting. The expansion into Holland Village and Clarke Quay reflects this shift, with both clinics designed to offer a comfortable and private environment that supports individuals in seeking care with confidence.

DTAP operates as a GP+ medical centre, bridging the gap between general practice and specialist care. Fully accredited for HIV and STD testing and treatment, its clinical protocols adhere to Singapore Ministry of Health (MOH) guidelines, covering the full continuum from screening and early detection through to treatment and long-term management. Beyond sexual health, DTAP also supports men’s and women’s health, weight management and mental health.

Clinics are staffed by experienced doctors — both male and female — who take a friendly, open and non-discriminatory approach, ensuring patients can seek care with confidence and discretion.

“This expansion builds on DTAP’s longstanding commitment to accessible and confidential care, with over 20 years of experience since 2005. We are seeing a clear shift towards more proactive health-seeking behaviour, particularly in sexual health, with more patients coming forward earlier for screening and testing, including for conditions that were previously under-discussed. This highlights the importance of timely detection and access to care, supported by a discreet, comfortable environment with experienced doctors who provide care in a respectful, open and non-discriminatory manner,” said Dr. Alan Tan, Chairman of DTAP Clinics.

DTAP Clinic @ Holland Village and DTAP Clinic @ Clarke Quay are now open to patients. For more information on services, visit https://dtapclinic.com/.

Hashtag: #DTAP

The issuer is solely responsible for the content of this announcement.

About DTAP

DTAP clinics offer GP+ medical services, bridging the gap between general practice and specialist care. Established in 2005, DTAP provides services that extend beyond regular GP offerings, with key focus areas including men’s health and women’s health, including sexual health, STD check, weight management and mental health. Through all life stages, DTAP aims to be a trusted healthcare partner in both general and sexual health.

Continue Reading

Media OutReach

TP’s AI-powered debt collection solution recovers up to 40% debt, improves efficiency and saves costs

Published

on

SINGAPORE – Media OutReach Newswire – 13 May 2026 – Global digital business services leader TP (ex-Teleperformance) today reported that its award-winning AI-powered collections solution, TP.ai FAB Collect, matched human-level customer satisfaction scores while delivering a 40% debt recovery rate in live client deployments.

Collections are emerging as a critical lever for both financial performance and customer retention. Regional institutions including the Asian Development Bank have identified digital transformation of financial services and credit infrastructure as a strategic priority across Asia, while rising consumer delinquencies are increasing pressure on banks to modernise servicing and collections operations.

However, debt collection remains one of banking’s most complex challenges, as lenders struggle to improve recovery rates without damaging customer relationships. AI-driven, human-supported debt collection models are emerging as a potential way forward to help lenders tackle rising credit risk and changing borrower behaviour. TP.ai FAB Collect is designed by training AI on decades of human collections expertise and deploying it where volume demands scale, so human advisors can focus on preserving customer relationships.

From Recovery to Relationship Management

TP.ai FAB Collect empowers lenders to operationalise more predictive, customer-centric engagement at scale, moving beyond traditional recovery models without adding friction to the customer experience. Built on TP’s proprietary TP.ai FAB (Foundational AI Backbone) framework, the solution integrates advanced analytics, AI-driven decisioning, and omnichannel engagement to improve recovery outcomes while maintaining compliance and customer trust.

“We trained our AI on 40 years of human collections expertise. Now it handles the first wave, so our human advisors can focus on the conversations that truly matter. TP.ai FAB Collect has produced results across debt recovery, promise-to-pay and overall customer satisfaction.” explains Assaf Tarnopolsky, TP’s Chief Business Development & Customer Officer, APAC.

When deployed by a leading financial institution, TP.ai FAB Collect’s AI agents achieved a customer satisfaction (CSAT) score that was slightly higher than human agents while also achieving a 40% debt recovery rate. At a leading telecommunications company, AI agents adapted outreach to customers based on local payment behaviour, achieving a 7%-point improvement in the pay-to-contact ratio compared to the human-only model. The solution also improved recovery performance over time while reducing collections costs by 40% compared to a human-only model.

TP.ai FAB Collect was recognised with a 2026 Artificial Intelligence Excellence Award by the Business Intelligence Group and was named Technology of the Year by the Excellence in Customer Service awards.

Hashtag: #TPAPAC #TPaiFAB


, a global leader in digital business services which consistently seeks to blend the best of advanced technology with human empathy to deliver enhanced customer care that is simpler, faster, and safer for the world’s biggest brands and their customers. The Group’s comprehensive, AI-powered service portfolio ranges from front office customer care to back-office functions, including operations consulting and high-value digital transformation services. It also offers a range of specialized services such as interpreting and localization, visa and consular services, and recruitment process outsourcing services. The teams of multilingual, inspired, and passionate experts and advisors, spread in close to 100 countries, as well as the Group’s local presence allows it to be a force of good in supporting communities, clients, and the environment.

For more information: .

Continue Reading

Trending